468 related articles for article (PubMed ID: 19375648)
1. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo.
Vlaski M; Lafarge X; Chevaleyre J; Duchez P; Boiron JM; Ivanovic Z
Exp Hematol; 2009 May; 37(5):573-84. PubMed ID: 19375648
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural and phenotypic analysis of in vitro erythropoiesis from human cord blood CD34+ cells.
Kie JH; Jung YJ; Woo SY; Ryu KH; Park HY; Chung WS; Seoh JY
Ann Hematol; 2003 May; 82(5):278-83. PubMed ID: 12679887
[TBL] [Abstract][Full Text] [Related]
3. PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells.
Sivertsen EA; Hystad ME; Gutzkow KB; Døsen G; Smeland EB; Blomhoff HK; Myklebust JH
Br J Haematol; 2006 Oct; 135(1):117-28. PubMed ID: 16965383
[TBL] [Abstract][Full Text] [Related]
4. Erythroid differentiation and maturation from peripheral CD34+ cells in liquid culture: cellular and molecular characterization.
Ronzoni L; Bonara P; Rusconi D; Frugoni C; Libani I; Cappellini MD
Blood Cells Mol Dis; 2008; 40(2):148-55. PubMed ID: 17889571
[TBL] [Abstract][Full Text] [Related]
5. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
7. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of in vivo murine erythropoietic response to sodium orthovanadate.
Aguirre MV; Juaristi JA; Alvarez MA; Brandan NC
Chem Biol Interact; 2005 Sep; 156(1):55-68. PubMed ID: 16137666
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin has a differentiative effect on late-stage human erythropoiesis.
Liu W; Wang M; Tang DC; Ding I; Rodgers GP
Br J Haematol; 1999 May; 105(2):459-69. PubMed ID: 10233422
[TBL] [Abstract][Full Text] [Related]
10. [In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].
Douay L; Giarratana MC
Bull Acad Natl Med; 2005 May; 189(5):903-13; discussion 914-5. PubMed ID: 16433462
[TBL] [Abstract][Full Text] [Related]
11. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and hydroxyurea can act on early erythroid progenitors from adult human peripheral blood to modulate fetal globin mRNA levels.
Stoeckert CJ; Green MB
Exp Hematol; 1994 Mar; 22(3):278-82. PubMed ID: 8112426
[TBL] [Abstract][Full Text] [Related]
13. New insights into the regulation of erythroid cells.
Ingley E; Tilbrook PA; Klinken SP
IUBMB Life; 2004 Apr; 56(4):177-84. PubMed ID: 15230344
[TBL] [Abstract][Full Text] [Related]
14. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant N-acetyl-L-cysteine inhibits erythropoietin-induced differentiation of erythroid progenitors derived from mouse fetal liver.
Nagata M; Arimitsu N; Ito T; Sekimizu K
Cell Biol Int; 2007 Mar; 31(3):252-6. PubMed ID: 17174578
[TBL] [Abstract][Full Text] [Related]
16. In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems.
Dorn I; Lazar-Karsten P; Boie S; Ribbat J; Hartwig D; Driller B; Kirchner H; Schlenke P
Transfusion; 2008 Jun; 48(6):1122-32. PubMed ID: 18298595
[TBL] [Abstract][Full Text] [Related]
17. Expression of red cell surface antigens during erythropoiesis.
Daniels G; Green C
Vox Sang; 2000; 78 Suppl 2():149-53. PubMed ID: 10938945
[TBL] [Abstract][Full Text] [Related]
18. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
19. NACA is a positive regulator of human erythroid-cell differentiation.
Lopez S; Stuhl L; Fichelson S; Dubart-Kupperschmitt A; St Arnaud R; Galindo JR; Murati A; Berda N; Dubreuil P; Gomez S
J Cell Sci; 2005 Apr; 118(Pt 8):1595-605. PubMed ID: 15784678
[TBL] [Abstract][Full Text] [Related]
20. Retrovirally-produced erythropoietin effectively induces differentiation and proliferation of J2E erythroid cells.
Busfield SJ; Riches KJ; Sainsbury AJ; Rossi E; Garcia-Webb P; Klinken SP
Growth Factors; 1993; 9(2):87-97. PubMed ID: 8217220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
